Prevention of preeclampsia;Prévention de la prééclampsie

Annales Francaises d'Anesthesie et de Reanimation

Volumn 29, Issue 3, 2010, Pages

  Deruelle, P ^a   Girard, J M ^a   Coutty, N ^a   Subtil, D ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Aspirin; Oxygen scavengers; Prevention of preeclampsia; Vitamin C; Vitamin E

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ASCORBIC ACID; CALCIUM; DIURETIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; NITRIC OXIDE;

ARTICLE; DRUG EFFICACY; DRUG INDUCED HEADACHE; HIGH RISK POPULATION; HUMAN; INCIDENCE; MALNUTRITION; PREECLAMPSIA; SUPPLEMENTATION;

ADOLESCENT; ADULT; ANTICOAGULANTS; ANTIOXIDANTS; ASPIRIN; CALCIUM COMPOUNDS; DIURETICS; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MALNUTRITION; NITRIC OXIDE DONORS; PLATELET AGGREGATION INHIBITORS; PRE-ECLAMPSIA; PREGNANCY; RISK; YOUNG ADULT;

EID: 77952549093     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2010.02.014     Document Type: Article

References (52)

1. Beaufils M., Uzan S., Donsimoni R., Colau J.C. Prevention of pre-eclampsia by early antiplatelet therapy. Lancet 1985, 1:840-842.
2. Benigni A., Gregorini G., Frusca T., Chiabrando C., Ballerini S., Valcamonico A., et al. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancyinduced hypertension. N Engl J Med 1989, 321:357-362.
3. McParland P., Pearce J.M., Chamberlain G.V. Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hypertension. Lancet 1990, 335:1552-1555.
4. Schiff E., Peleg E., Goldenberg M., Rosenthal T., Ruppin E., Tamarkin M., et al. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N Engl J Med 1989, 321:351-356.
5. Wallenburg H.C., Dekker G.A., Makovitz J.W., Rotmans P. Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet 1986, 1:1-3.
6. Wallenburg H.C., Rotmans N. Prevention of recurrent idiopathic fetal growth retardation by low-dose aspirin and dipyridamole. Am J Obstet Gynecol 1987, 157:1230-1235.
7. Sibai B.M., Caritis S.N., Thom E., Klebanoff M., McNellis D., Rocco L., et al. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1993, 329:1213-1218.
8. CLASP Collaborative Group: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994;343:619-29.
9. ECPPA Collaborative Group: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. Br J Obstet Gynaecol 1996;103:39-47.
10. Herabutya Y., Jetsawangsri T., Saropala N. The use of low-dose aspirin to prevent preeclampsia. Int J Gynaecol Obstet 1996, 54:177-178.
11. Caritis S., Sibai B., Hauth J., Lindheimer M.D., Klebanoff M., Thom E., et al. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998, 338:701-705.
12. Golding J. A. randomised trial of low dose aspirin for primiparae in pregnancy. The Jamaica Low Dose Aspirin Study Group. Br J Obstet Gynaecol 1998, 105:293-299.
13. Rotchell Y.E., Cruickshank J.K., Gay M.P., Griffiths J., Stewart A., Farrell B., et al. Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications. Br J Obstet Gynaecol 1998, 105:286-292.
14. Subtil D., Goeusse P., Puech F., Lequien P., Biausque S., Breart G., et al. Aspirin (100mg) used for prevention of pre-eclampsia in nulliparous women: the Essai Regional Aspirine Mere-Enfant study (Part 1). BJOG 2003, 110:475-484.
15. Duley L., Henderson-Smart D., Knight M., King J. Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review. BMJ 2001, 322:329-333.
16. Duley L., Henderson-Smart D.J., Meher S., King J.F. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2007, CD004659.
17. Clarke M., Oxman A. Cochrane Reviewers handbook 4.1.2 [updated March 2001]. In: The Cochrane Library, Issue 2. Oxford: Update Software. Updated quarterly; 2001. NA.
18. Askie L.M., Duley L., Henderson-Smart D.J., Stewart L.A. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 2007, 369:1791-1798.
19. Hermida R.C., Ayala D.E., Iglesias M., Mojon A., Silva I., Ucieda R., et al. Time-dependent effects of lowdose aspirin administration on blood pressure in pregnant women. Hypertension 1997, 30:589-595.
20. Hermida R.C., Ayala D.E., Calvo C., Lopez J.E., Fernandez J.R., Mojon A., et al. Administration time-dependent effects of aspirin on blood pressure in untreated hypertensive patients. Hypertension 2003, 41:1259-1267.
21. Sergio F., Maria Clara D., Gabriella F., Giorgia S., Sara De C., Giancarlo P., et al. Prophylaxis of recurrent preeclampsia: low-molecular-weight heparin plus low-dose aspirin versus low-dose aspirin alone. Hypertens Pregnancy 2006, 25:115-127.
22. Riyazi N., Leeda M., de Vries J.I., Huijgens P.C., van Geijn H.P., Dekker G.A. Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study. Eur J Obstet Gynecol Reprod Biol 1998, 80:49-54.
23. Leduc L, Dubois E, Takser L, Rey E, David M, Dalteparin and low-dose aspirin in the prevention of adverse obstetric outcomes in women with inherited thrombophilia. J Obstet Gynaecol Can 2007;29:787-93.
24. Kupferminc M.J., Fait G., Many A., Lessing J.B., Yair D., Bar-Am A., et al. Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias. Hypertens Pregnancy 2001, 20:35-44.
25. Kalk J.J., Huisjes A.J., de Groot C.J., van Beek E., van Pampus M.G., Spaanderman M.E., et al. Recurrence rate of pre-eclampsia in women with thrombophilia influenced by low-molecular-weight heparin treatment?. Neth J Med 2004, 62:83-87.
26. Dolitzky M., Inbal A., Segal Y., Weiss A., Brenner B., Carp H. A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages. Fertil Steril 2006, 86:362-366.
27. Bar J., Mashiah R., Cohen-Sacher B., Hod M., Orvieto R., Ben-Rafael Z., et al. Effect of thrombophylaxis on uterine and fetal circulation in pregnant women with a history of pregnancy complications. Thromb Res 2001, 101:235-241.
28. Alguel G., Vormittag R., Simanek R., Kyrle P.A., Quehenberger P., Mannhalter C., et al. Preeclampsia and pregnancy loss in women with a history of venous thromboembolism and prophylactic low-molecularweight heparin (LMWH) during pregnancy. Thromb Haemost 2006, 96:285-289.
29. Mello G., Parretti E., Fatini C., Riviello C., Gensini F., Marchionni M., et al. Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensinconverting enzyme DD women. Hypertension 2005, 45:86-91.
30. Rumbold A., Duley L., Crowther C., Haslam R. Antioxidants for preventing pre-eclampsia. Cochrane Database Syst Rev 2005, CD004227.
31. People's League of Health. Nutrition of expectant and nursing mothers: interim report. Lancet 1942;2:10-2.
32. Rumbold A.R., Crowther C.A., Haslam R.R., Dekker G.A., Robinson J.S. Vitamins C and E and the risks of preeclampsia and perinatal complications. N Engl J Med 2006, 354:1796-1806.
33. Poston L., Briley A.L., Seed P.T., Kelly F.J., Shennan A.H. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 2006, 367:1145-1154.
34. Hofmeyr G., Atallah A., Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 2006, 3:CD001059.
35. Taufield P.A., Ales K.L., Resnick L.M., Druzin M.L., Gertner J.M., Laragh J.H. Hypocalciuria in preeclampsia. N Engl J Med 1987, 316:715-718. NA.
36. Crowther C.A., Hiller J.E., Pridmore B., Bryce R., Duggan P., Hague W.M., et al. Calcium supplementation in nulliparous women for the prevention of pregnancy-induced hypertension, preeclampsia and preterm birth: an Australian randomized trial. FRACOG and the ACT Study Group. Aust N Z J Obstet Gynaecol 1999, 39:12-18.
37. Levine R.J., Hauth J.C., Curet L.B., Sibai B.M., Catalano P.M., Morris C.D., et al. Trial of calcium to prevent preeclampsia. N Engl J Med 1997, 337:69-76.
38. Lopez-Jaramillo P., Delgado F., Jacome P., Teran E., Ruano C., Rivera J. Calcium supplementation and the risk of preeclampsia in Ecuadorian pregnant teenagers. Obstet Gynecol 1997, 90:162-167.
39. Villar J., Abdel-Aleem H., Merialdi M., Mathai M., Ali M.M., Zavaleta N., et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. Am J Obstet Gynecol 2006, 194:639-649.
40. Niromanesh S., Laghaii S., Mosavi-Jarrahi A. Supplementary calcium in prevention of pre-eclampsia. Int J Gynaecol Obstet 2001, 74:17-21.
41. Jonsson B., Hauge B., Larsen M.F., Hald F. Zinc supplementation during pregnancy: a double blind randomised controlled trial. Acta Obstet Gynecol Scand 1996, 75:725-729.
42. Mahomed K., James D.K., Golding J., McCabe R. Zinc supplementation during pregnancy: a double blind randomised controlled trial. BMJ 1989, 299:826-830.
43. Sibai B.M., Villar M.A., Bray E. Magnesium supplementation during pregnancy: a double-blind randomized controlled clinical trial. Am J Obstet Gynecol 1989, 161:115-119.
44. Skajaa K., Dorup I., Sandstrom B.M. Magnesium intake and status and pregnancy outcome in a Danish population. Br J Obstet Gynaecol 1991, 98:919-928.
45. Davis D.G., Brown P.M. Re: glyceryl trinitrate (GTN) patches are unsuitable in hypertensive pregnancy. Aust N Z J Obstet Gynaecol 2001, 41:474.
46. Lees C., Valensise H., Black R., Harrington K., Byiers S., Romanini C., et al. The efficacy and fetal-maternal cardiovascular effects of transdermal glyceryl trinitrate in the prophylaxis of pre-eclampsia and its complications: a randomized double-blind placebo-controlled trial. Ultrasound Obstet Gynecol 1998, 12:334-338.
47. Meher S., Duley L. Nitric oxide for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2007, 2:CD006490.
48. Picciolo C., Roncaglia N., Neri I., Pasta F., Arreghini A., Facchinetti F. Nitric oxide in the prevention of pre-eclampsia. Prenat Neonatal Med 2000, 5:212-215.
49. Churchill D., Beevers G.D., Meher S., Rhodes C. Diuretics for preventing pre-eclampsia. Cochrane Database Syst Rev 2007, (1):CD004451.
50. Ziaei S., Hantoshzadeh S., Rezasoltani P., Lamyian M. The effect of garlic tablet on plasma lipids and platelet aggregation in nulliparous pregnants at high risk of preeclampsia. Eur J Obstet Gynecol Reprod Biol 2001, 99:201-206.
51. Meher S., Duley L. Rest during pregnancy for preventing pre-eclampsia and its complications in women with normal blood pressure. Cochrane Database Syst Rev 2006, 2:CD005939.
52. Meher S., Duley L. Exercise or other physical activity for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2006, 2:CD005942.